Further analysis with reference to the TCGA database found that FASN mRNA expression was significantly increased in HCC as compared to the normal control group and there was a strong correlation between FASN mRNA levels and poor progression-free interval (PFI) and overall survival (OS) (p < 0.01, Fig. 3A). This evidence concerns the gene FASN and hepatocellular carcinoma.